AVH charting perspective, page-45

I anticipate uptake in the U.S will accelerate in the next half. The RECELL device has been proven to diminish the application process compared to current traditional methods, cost effective ie: has been proven to save major burns centres millions of dollars annually. Aesthetic positive outcomes of proven scar reduction or no residue scar formation was evident through Avita’s presentation. This has been a long time in the making but now with U.S FDA approval and CFDA approval etc AVH’s future appears to be on its way to become a blue chip in the making. All IMO. I base my comments based on factual info that I have previously mentioned in prior posts.

K